A18V (p.Ala18Val) variant of IFNGR2 (Interferon gamma receptor 2)

A18V (p.Ala18Val) in IFNGR2 (Interferon gamma receptor 2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Immunodeficiency 28. The available variant effect predictions contribute to a CATVariant prioritization score of 0.16 / 1. The record also includes population frequency data and structural context.

A18V (p.Ala18Val) variant details